Invention Publication
- Patent Title: COMBINATION COMPRISING A NEUROTENSIN RECEPTOR BINDING COMPOUND, GEMCITABINE AND NAB-PACLITAXEL
-
Application No.: US18541604Application Date: 2023-12-15
-
Publication No.: US20240197927A1Publication Date: 2024-06-20
- Inventor: Diane-Charlotte Imbs , Elodie Lewkowicz , Alexander McEwan , Thomas Rohban , Sylvie Rolland , Daniel Stevens , John R. Forbes
- Applicant: Fusion Pharmaceuticals Inc.
- Applicant Address: CA Hamilton
- Assignee: Fusion Pharmaceuticals Inc.
- Current Assignee: Fusion Pharmaceuticals Inc.
- Current Assignee Address: CA Hamilton
- Main IPC: A61K51/04
- IPC: A61K51/04 ; A61K31/7068 ; A61K47/64 ; A61P35/00
Abstract:
The present invention relates to a combination comprising a neurotensin receptor binding compound, gemcitabine and nab-paclitaxel for use for the treatment of a neurotensin receptor overexpressing tumour in a subject.
Information query
